The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro

Marija Dulovic, Maja Jovanovic, Maria Xilouri, Leonidas Stefanis, Ljubica Harhaji-Trajkovic, Tamara Kravic-Stevovic, Verica Paunovic, Mustafa T. Ardah, Omar Ali El-Agnaf, Vladimir Kostic, Ivanka Markovic, Vladimir Trajkovic

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

In the present study, we investigated the role of the main intracellular energy sensor, AMP-activated protein kinase (AMPK), in the in vitro neurotoxicity of α-synuclein (ASYN), one of the key culprits in the pathogenesis of Parkinson's disease. The loss of viability in retinoic acid-differentiated SH-SY5Y human neuroblastoma cells inducibly overexpressing wild-type ASYN was associated with the reduced activation of AMPK and its activator LKB1, as well as AMPK target Raptor. ASYN-overexpressing rat primary neurons also displayed lower activity of LKB1/AMPK/Raptor pathway. Restoration of AMPK activity by metformin or AICAR reduced the in vitro neurotoxicity of ASYN overexpression, acting independently of the prosurvival kinase Akt or the induction of autophagic response. The conditioned medium from ASYN-overexpressing cells, containing secreted ASYN, as well as dopamine-modified or nitrated recombinant ASYN oligomers, all inhibited AMPK activation in differentiated SH-SY5Y cells and reduced their viability, but not in the presence of metformin or AICAR. The RNA interference-mediated knockdown of AMPK increased the sensitivity of SH-SY5Y cells to the harmful effects of secreted ASYN. AMPK-dependent protection from extracellular ASYN was also observed in rat neuron-like pheochromocytoma cell line PC12. These data demonstrate the protective role of AMPK against the toxicity of both intracellular and extracellular ASYN, suggesting that modulation of AMPK activity may be a promising therapeutic strategy in Parkinson's disease.

Original languageEnglish
Pages (from-to)1-11
Number of pages11
JournalNeurobiology of Disease
Volume63
DOIs
Publication statusPublished - 2014
Externally publishedYes

Fingerprint

alpha-Synuclein
AMP-Activated Protein Kinases
Raptors
Metformin
Parkinson Disease
Synucleins
In Vitro Techniques
Neurons
PC12 Cells
Conditioned Culture Medium
RNA Interference
Tretinoin
Neuroblastoma
Dopamine
Phosphotransferases

Keywords

  • AICAR
  • Akt
  • Alpha-synuclein
  • AMPK
  • Autophagy
  • Metformin
  • Neuroprotection
  • Neurotoxicity

ASJC Scopus subject areas

  • Neurology

Cite this

Dulovic, M., Jovanovic, M., Xilouri, M., Stefanis, L., Harhaji-Trajkovic, L., Kravic-Stevovic, T., ... Trajkovic, V. (2014). The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro. Neurobiology of Disease, 63, 1-11. https://doi.org/10.1016/j.nbd.2013.11.002

The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro. / Dulovic, Marija; Jovanovic, Maja; Xilouri, Maria; Stefanis, Leonidas; Harhaji-Trajkovic, Ljubica; Kravic-Stevovic, Tamara; Paunovic, Verica; Ardah, Mustafa T.; Ali El-Agnaf, Omar; Kostic, Vladimir; Markovic, Ivanka; Trajkovic, Vladimir.

In: Neurobiology of Disease, Vol. 63, 2014, p. 1-11.

Research output: Contribution to journalArticle

Dulovic, M, Jovanovic, M, Xilouri, M, Stefanis, L, Harhaji-Trajkovic, L, Kravic-Stevovic, T, Paunovic, V, Ardah, MT, Ali El-Agnaf, O, Kostic, V, Markovic, I & Trajkovic, V 2014, 'The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro', Neurobiology of Disease, vol. 63, pp. 1-11. https://doi.org/10.1016/j.nbd.2013.11.002
Dulovic M, Jovanovic M, Xilouri M, Stefanis L, Harhaji-Trajkovic L, Kravic-Stevovic T et al. The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro. Neurobiology of Disease. 2014;63:1-11. https://doi.org/10.1016/j.nbd.2013.11.002
Dulovic, Marija ; Jovanovic, Maja ; Xilouri, Maria ; Stefanis, Leonidas ; Harhaji-Trajkovic, Ljubica ; Kravic-Stevovic, Tamara ; Paunovic, Verica ; Ardah, Mustafa T. ; Ali El-Agnaf, Omar ; Kostic, Vladimir ; Markovic, Ivanka ; Trajkovic, Vladimir. / The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro. In: Neurobiology of Disease. 2014 ; Vol. 63. pp. 1-11.
@article{84b15cd994d041ccb105848b629524ce,
title = "The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro",
abstract = "In the present study, we investigated the role of the main intracellular energy sensor, AMP-activated protein kinase (AMPK), in the in vitro neurotoxicity of α-synuclein (ASYN), one of the key culprits in the pathogenesis of Parkinson's disease. The loss of viability in retinoic acid-differentiated SH-SY5Y human neuroblastoma cells inducibly overexpressing wild-type ASYN was associated with the reduced activation of AMPK and its activator LKB1, as well as AMPK target Raptor. ASYN-overexpressing rat primary neurons also displayed lower activity of LKB1/AMPK/Raptor pathway. Restoration of AMPK activity by metformin or AICAR reduced the in vitro neurotoxicity of ASYN overexpression, acting independently of the prosurvival kinase Akt or the induction of autophagic response. The conditioned medium from ASYN-overexpressing cells, containing secreted ASYN, as well as dopamine-modified or nitrated recombinant ASYN oligomers, all inhibited AMPK activation in differentiated SH-SY5Y cells and reduced their viability, but not in the presence of metformin or AICAR. The RNA interference-mediated knockdown of AMPK increased the sensitivity of SH-SY5Y cells to the harmful effects of secreted ASYN. AMPK-dependent protection from extracellular ASYN was also observed in rat neuron-like pheochromocytoma cell line PC12. These data demonstrate the protective role of AMPK against the toxicity of both intracellular and extracellular ASYN, suggesting that modulation of AMPK activity may be a promising therapeutic strategy in Parkinson's disease.",
keywords = "AICAR, Akt, Alpha-synuclein, AMPK, Autophagy, Metformin, Neuroprotection, Neurotoxicity",
author = "Marija Dulovic and Maja Jovanovic and Maria Xilouri and Leonidas Stefanis and Ljubica Harhaji-Trajkovic and Tamara Kravic-Stevovic and Verica Paunovic and Ardah, {Mustafa T.} and {Ali El-Agnaf}, Omar and Vladimir Kostic and Ivanka Markovic and Vladimir Trajkovic",
year = "2014",
doi = "10.1016/j.nbd.2013.11.002",
language = "English",
volume = "63",
pages = "1--11",
journal = "Neurobiology of Disease",
issn = "0969-9961",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro

AU - Dulovic, Marija

AU - Jovanovic, Maja

AU - Xilouri, Maria

AU - Stefanis, Leonidas

AU - Harhaji-Trajkovic, Ljubica

AU - Kravic-Stevovic, Tamara

AU - Paunovic, Verica

AU - Ardah, Mustafa T.

AU - Ali El-Agnaf, Omar

AU - Kostic, Vladimir

AU - Markovic, Ivanka

AU - Trajkovic, Vladimir

PY - 2014

Y1 - 2014

N2 - In the present study, we investigated the role of the main intracellular energy sensor, AMP-activated protein kinase (AMPK), in the in vitro neurotoxicity of α-synuclein (ASYN), one of the key culprits in the pathogenesis of Parkinson's disease. The loss of viability in retinoic acid-differentiated SH-SY5Y human neuroblastoma cells inducibly overexpressing wild-type ASYN was associated with the reduced activation of AMPK and its activator LKB1, as well as AMPK target Raptor. ASYN-overexpressing rat primary neurons also displayed lower activity of LKB1/AMPK/Raptor pathway. Restoration of AMPK activity by metformin or AICAR reduced the in vitro neurotoxicity of ASYN overexpression, acting independently of the prosurvival kinase Akt or the induction of autophagic response. The conditioned medium from ASYN-overexpressing cells, containing secreted ASYN, as well as dopamine-modified or nitrated recombinant ASYN oligomers, all inhibited AMPK activation in differentiated SH-SY5Y cells and reduced their viability, but not in the presence of metformin or AICAR. The RNA interference-mediated knockdown of AMPK increased the sensitivity of SH-SY5Y cells to the harmful effects of secreted ASYN. AMPK-dependent protection from extracellular ASYN was also observed in rat neuron-like pheochromocytoma cell line PC12. These data demonstrate the protective role of AMPK against the toxicity of both intracellular and extracellular ASYN, suggesting that modulation of AMPK activity may be a promising therapeutic strategy in Parkinson's disease.

AB - In the present study, we investigated the role of the main intracellular energy sensor, AMP-activated protein kinase (AMPK), in the in vitro neurotoxicity of α-synuclein (ASYN), one of the key culprits in the pathogenesis of Parkinson's disease. The loss of viability in retinoic acid-differentiated SH-SY5Y human neuroblastoma cells inducibly overexpressing wild-type ASYN was associated with the reduced activation of AMPK and its activator LKB1, as well as AMPK target Raptor. ASYN-overexpressing rat primary neurons also displayed lower activity of LKB1/AMPK/Raptor pathway. Restoration of AMPK activity by metformin or AICAR reduced the in vitro neurotoxicity of ASYN overexpression, acting independently of the prosurvival kinase Akt or the induction of autophagic response. The conditioned medium from ASYN-overexpressing cells, containing secreted ASYN, as well as dopamine-modified or nitrated recombinant ASYN oligomers, all inhibited AMPK activation in differentiated SH-SY5Y cells and reduced their viability, but not in the presence of metformin or AICAR. The RNA interference-mediated knockdown of AMPK increased the sensitivity of SH-SY5Y cells to the harmful effects of secreted ASYN. AMPK-dependent protection from extracellular ASYN was also observed in rat neuron-like pheochromocytoma cell line PC12. These data demonstrate the protective role of AMPK against the toxicity of both intracellular and extracellular ASYN, suggesting that modulation of AMPK activity may be a promising therapeutic strategy in Parkinson's disease.

KW - AICAR

KW - Akt

KW - Alpha-synuclein

KW - AMPK

KW - Autophagy

KW - Metformin

KW - Neuroprotection

KW - Neurotoxicity

UR - http://www.scopus.com/inward/record.url?scp=84890263516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890263516&partnerID=8YFLogxK

U2 - 10.1016/j.nbd.2013.11.002

DO - 10.1016/j.nbd.2013.11.002

M3 - Article

VL - 63

SP - 1

EP - 11

JO - Neurobiology of Disease

JF - Neurobiology of Disease

SN - 0969-9961

ER -